Treat to target: a winner strategy in rheumatology. From the past to the future
-
Published:2022-01-25
Issue:3
Volume:3
Page:
-
ISSN:2612-5110
-
Container-title:Beyond Rheumatology
-
language:
-
Short-container-title:Beyond Rheumatol
Author:
Bruner Vincenzo,
Migliore AlbertoORCID
Publisher
PAGEPress Publications
Reference30 articles.
1. Smolen JS, Aletaha D, Bijlsma JW, et al. T2T Expert Committee Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010;69:631-7.
2. Grigor C, Capell H, Stirling A, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004;364:263-9.
3. Wakefield RJ, D’Agostino MA, Naredo E, et al. After treat-to-target: can a targeted ultrasound initiative improve RA outcomes?. Ann Rheum Dis 2012;71:799-803.
4. Atar D, Birkeland KI, Uhlig T. 'Treat to target': moving targets from hypertension, hyperlipidaemia and diabetes to rheumatoid arthritis. Ann Rheum Dis 2010;69:629-30.
5. Janke K, Biester K, Krause D, et al. Comparative effectiveness of biological medicines in rheumatoid arthritis: systematic review and network meta-analysis including aggregate results from reanalysed individual patient data. BMJ 2020;370:m2288.